These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 30395988)

  • 21. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in Taiwan.
    Kuo LK; Chang HT; Hsueh SC; Liu IM; Hsieh PC; Jean SS
    J Microbiol Immunol Infect; 2024 Oct; 57(5):801-811. PubMed ID: 39147627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
    Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
    Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.
    Pop-Vicas AE; D'Agata EM
    Clin Infect Dis; 2005 Jun; 40(12):1792-8. PubMed ID: 15909268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Vardakas KZ; Falagas ME
    Int J Antimicrob Agents; 2017 Feb; 49(2):233-238. PubMed ID: 27686609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous colistin for the management of multidrug-resistant bacterial infections in Indian patients.
    Wilfred PM; Chandy SJ; Rebecca G; Satyendra S; Jasmine S
    Trop Doct; 2021 Jul; 51(3):301-306. PubMed ID: 33491607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of colistin in adult patients: A cross-sectional study.
    Giacobbe DR; Saffioti C; Losito AR; Rinaldi M; Aurilio C; Bolla C; Boni S; Borgia G; Carannante N; Cassola G; Ceccarelli G; Corcione S; Dalla Gasperina D; De Rosa FG; Dentone C; Di Bella S; Di Lauria N; Feasi M; Fiore M; Fossati S; Franceschini E; Gori A; Granata G; Grignolo S; Grossi PA; Guadagnino G; Lagi F; Maraolo AE; Marinò V; Mazzitelli M; Mularoni A; Oliva A; Pace MC; Parisini A; Patti F; Petrosillo N; Pota V; Raffaelli F; Rossi M; Santoro A; Tascini C; Torti C; Trecarichi EM; Venditti M; Viale P; Signori A; Bassetti M; Del Bono V; Giannella M; Mikulska M; Tumbarello M; Viscoli C;
    J Glob Antimicrob Resist; 2020 Mar; 20():43-49. PubMed ID: 31207379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.
    Karaiskos I; Giamarellou H
    Expert Opin Pharmacother; 2014 Jul; 15(10):1351-70. PubMed ID: 24766095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reinforcement of an antimicrobial stewardship task force aims at a better use of antibiotics of last resort: the COLITIFOS study.
    Davido B; Bouchand F; Dinh A; Perronne C; Villart M; Senard O; Salomon J
    Int J Antimicrob Agents; 2017 Aug; 50(2):142-147. PubMed ID: 28694232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
    Gibson GA; Bauer SR; Neuner EA; Bass SN; Lam SW
    Antimicrob Agents Chemother; 2016 Jan; 60(1):431-6. PubMed ID: 26525802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review.
    Genis C; Kaman A; Öztürk B; Tanır G
    Eur J Pediatr; 2024 Aug; 183(8):3407-3415. PubMed ID: 38767692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wards.
    Maraki S; Mavros MN; Kofteridis DP; Samonis G; Falagas ME
    Surg Infect (Larchmt); 2012 Oct; 13(5):326-31. PubMed ID: 23013255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
    Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
    Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.